U.S. Consumer Durables Stock News

In recent days, Leidos Holdings drew increased attention as a sector-wide rally in defense technology followed peer Parsons’ announcement of a US$392 million federal contract, spotlighting government IT and defense-focused firms. This broader interest in defense technology also coincided with routine executive stock deferral and dividend-equivalent transactions at Leidos, underscoring ongoing alignment between leadership compensation and long-term equity. Now we’ll explore how this...

In recent days, Saia attracted attention after several research firms, including Susquehanna and Stephens & Co., updated their views on the company and reiterated confidence in its operations as a major less-than-truckload carrier. This wave of analyst optimism is especially interesting given Saia’s earlier operational challenges, suggesting that professional observers still see resilience in its business model. We’ll now examine how this renewed analyst confidence, particularly the...

Vulcan Materials (VMC) is drawing fresh attention as US infrastructure spending and housing demand continue to support its aggregates, asphalt and concrete business, highlighting its pricing power and long-term contract profile for investors. See our latest analysis for Vulcan Materials. At a share price of US$292.12, Vulcan Materials has seen some recent volatility, with a 1-day share price return of 2.58% decline and a softer 90-day share price return of 3.56% decline, while its 1-year...

In early January 2026, Allstate announced that it will release its fourth-quarter 2025 results on February 4, 2026, followed by a conference call on February 5, while concurrent SEC filings and insider share transactions by the CEO and several directors highlighted ongoing activity in the company’s ownership and disclosure calendar. The combination of upcoming earnings, optimistic analyst expectations for improved profitability, and board-level stock compensation elections has sharpened...

Why LifeStance Health Group Is On Investors’ Radar LifeStance Health Group (LFST) has drawn attention after recent share price moves, with the stock closing at US$7.30. That puts fresh focus on how its growth profile and valuation currently line up. See our latest analysis for LifeStance Health Group. The recent 30 day share price return of 13.88% and 90 day share price return of 36.19% suggest momentum has been building. However, the 1 year total shareholder return shows a decline of 5.19%,...

In early January 2026, Virgin Galactic restructured its debt by extending maturities to 2028, issuing higher-interest obligations, and raising fresh equity with attached warrants, moves that increase both interest costs and shareholder dilution as it postpones commercial flight operations until at least late 2026. The company now openly signals that it does not expect to be profitable in 2026 or 2027, underscoring how dependent its long-term vision is on future execution and demand in the...

Why this new security product is attracting attention CommScope Holding Company (COMM) is drawing fresh interest after announcing an out of the box bootloader signing solution for Texas Instruments’ Arm based AM6x processors. This solution is built on its PRiSM security platform. The package focuses on hardware backed key protection, centralized key lifecycle management, and secure boot support. It aims to help device makers address emerging cybersecurity mandates such as the EU Cyber...

Bank First (BFC) has drawn fresh attention after recent share performance, including a 6.6% decline over the past month and a 5.5% decline over the past 3 months, despite solid longer term returns. See our latest analysis for Bank First. That recent 6.6% 1 month share price decline and 5.5% 3 month share price decline sit against a far stronger picture in the background, with a 32.1% 1 year total shareholder return pointing to fading short term momentum after substantial gains. If Bank...

The simplest way to invest in stocks is to buy exchange traded funds. But you can significantly boost your returns by...

Atlantic Union Bankshares recently reported quarterly results showing US$380.2 million in revenue, up very strongly year on year and roughly matching analyst expectations, but with net interest income coming in below forecasts. This mix of headline revenue growth alongside weaker core lending income has sharpened investor focus on how the bank balances growth, funding costs, and profitability in a challenging regional banking landscape. We’ll now examine how the significant miss in net...

Phillips Edison (PECO) has caught investor attention after recent trading left the stock around $35.20, with returns mixed over the past year and a modest gain in the past 3 months. See our latest analysis for Phillips Edison. At the current share price of $35.20, Phillips Edison’s recent 4.36% 90 day share price return contrasts with a slightly negative year to date share price return of 0.20%, while the 3 year total shareholder return of 18.68% suggests momentum has built more over the...

Criteo announced that its board has approved moving the company’s legal domicile from France to Luxembourg and replacing its American Depositary Shares with ordinary shares directly listed on Nasdaq, with shareholders set to vote on the conversion on February 27, 2026. This legal and listing overhaul could reshape how global investors access Criteo and influence its corporate governance, tax profile, and future listing flexibility. We’ll now explore how Criteo’s shift to a Luxembourg...

In recent days, ON Semiconductor has launched a greatly expanded US$6.00 billion share repurchase program and advanced a 650V Gallium Nitride power semiconductor initiative with GlobalFoundries, backed by European Union subsidies for capacity expansion in Dresden. This combination of sizeable capital returns and a push into higher-value power solutions for AI data centers and electrified transport underscores how ON Semiconductor is reshaping its portfolio toward areas where efficient energy...

What Crinetics Pharmaceuticals Stock’s Recent Move Might Mean for Investors Crinetics Pharmaceuticals (CRNX) has drawn attention after recent share price gains over the past week and month, prompting investors to reassess how its clinical-stage pipeline and current valuation line up. See our latest analysis for Crinetics Pharmaceuticals. Those sharp short term share price returns, including a 16.1% 1 day move to about $53.34, sit within a wider pattern. The 90 day share price return of 16.6%...

In early January 2026, JPMorgan downgraded Principal Financial Group’s stock rating from Overweight to Neutral, while maintaining a cautiously positive view on the company’s fundamentals. The bank’s move was driven more by seeing comparatively better value in other life insurers than by any deterioration in Principal’s outlook, which still includes an upbeat view on asset management flows. With JPMorgan’s downgrade emphasizing relative value within life insurers, we’ll examine how this...

Zimmer Biomet Holdings (ZBH) has come back into focus after Evercore ISI Group shifted its rating to Outperform, a change that follows earlier downgrades such as Raymond James moving to Market Perform. See our latest analysis for Zimmer Biomet Holdings. Zimmer Biomet’s recent rating upgrade comes after a mixed share price return pattern, with a 3.1% 7 day gain contrasting with a 4.8% 90 day share price decline and a weaker 1 year total shareholder return of 7.8%. This suggests momentum has...

Cantor Fitzgerald recently reiterated its positive view on Essex Property Trust, emphasizing the REIT’s stable West Coast apartment fundamentals, strong balance sheet, and its approximately 4% dividend yield as investors refocus on the sector ahead of upcoming earnings. Essex’s recent US$350,000,000 unsecured notes offering, used to refinance debt and support general corporate needs, adds financial flexibility that could be important as analysts highlight rising M&A interest across the U.S...

Mattel (MAT) has attracted fresh attention after screening as a value candidate, with recent share performance and fundamentals prompting investors to reassess how its toy and family entertainment business is currently being priced. See our latest analysis for Mattel. At a share price of $21.63, Mattel has recently seen a 9.02% 7-day share price return and a 19.50% 90-day share price return, while its 1-year total shareholder return sits at 17.36%. These figures may be influencing how...

U-Haul Holding Company recently released its latest Growth Index highlighting continued in-migration to Texas and Florida and persistent out-migration from California, while also reaffirming its role as one of North America’s largest moving and self-storage providers. On 8 January 2026, U-Haul’s participation at KeyBanc Capital Markets’ Self-Storage Investor Forum in New York gave investors direct insight into how these migration flows intersect with the company’s extensive network of more...

AbCellera Biologics recently resolved a legal dispute with Bruker Corporation, securing a US$36,000,000 upfront payment plus future royalties, and added renowned scientist Stephen Quake to its board. This combination of new cash inflow and scientific leadership could meaningfully influence AbCellera’s funding flexibility and decision-making around its pipeline. We’ll now explore how the Bruker settlement’s upfront cash and royalty potential may reshape AbCellera’s existing investment...

InterDigital, Inc. recently renewed a five-year, worldwide, non-exclusive, royalty-bearing license with a major Chinese vendor covering its smartphones and other cellular-enabled devices under InterDigital’s standard essential cellular, WiFi, and HEVC patents. This renewal underlines the importance of long-term licensing agreements for InterDigital just as investors are also weighing insider share sale plans and unresolved patent litigation with Amazon. We’ll now examine how the renewed...

Recent commentary around Amneal Pharmaceuticals (AMRX) has turned more focused as analysts highlight its revenue growth, earnings outlook, and mix of specialty drugs and government contracts, all coinciding with the stock’s recent positive momentum. See our latest analysis for Amneal Pharmaceuticals. At a share price of US$13.26, Amneal’s recent 1-month share price return of 11.71% and 90-day share price return of 28.86% line up with a very large 3-year total shareholder return. This suggests...

In the past week, MSA Safety reported a strong third quarter, with revenue rising 8.3% year on year and beating analyst expectations, while continuing to roll out connected safety offerings and integrate recent acquisitions such as M&C TechGroup and Lincoln Electric’s head protection business. At the same time, expanded fixed gas-detection and head protection portfolios, along with new remote monitoring solutions and long-running firefighter gear programs, highlight how MSA is deepening its...

Recently, Guardian Pharmacy Services, Inc. saw one of its Jan 16, 2026 US$40.00 call options become among the highest implied volatility equity contracts, pointing to intense options market interest in the name. This surge in implied volatility suggests traders are bracing for a meaningful company-specific event, highlighting Guardian Pharmacy Services as a focus of heightened speculation and attention. We’ll now examine how this spike in implied volatility around Guardian Pharmacy Services’...